Published in Eur Heart J on November 01, 1987
Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ (1989) 3.32
Management of aneurysmal subarachnoid hemorrhage. Crit Care Med (2009) 1.76
Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab (2011) 1.58
Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res (2013) 1.49
Incidence of and factors associated with manipulation of nimodipine dosage in patients with aneurysmal subarachnoid hemorrhage. Can J Hosp Pharm (2014) 0.93
Treatment options for cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurotherapeutics (2012) 0.89
Current controversies in the prediction, diagnosis, and management of cerebral vasospasm: where do we stand? Neurol Res Int (2013) 0.82
Role of calcitonin gene-related peptide in cerebral vasospasm, and as a therapeutic approach to subarachnoid hemorrhage. Front Endocrinol (Lausanne) (2012) 0.77
Persistent autoregulatory disturbance after angioplasty for cerebral vasospasm. A case report. Interv Neuroradiol (2004) 0.75
Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions? Hosp Pharm (2014) 0.75
Patient-to-patient transmission of HIV in private surgical consulting rooms. Lancet (1994) 4.12
Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. Br Med J (Clin Res Ed) (1982) 3.71
Access to stroke care in England, Wales and Northern Ireland: the effect of age, gender and weekend admission. Age Ageing (2007) 2.80
Evidence for a link between mortality in acute COPD and hospital type and resources. Thorax (2003) 2.63
Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations. Thorax (2010) 2.38
Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax (2002) 2.22
Airborne contamination of wounds in joint replacement operations: the relationship to sepsis rates. J Hosp Infect (1983) 2.20
IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol (1992) 2.09
Tonsillectomy technique as a risk factor for postoperative haemorrhage. Lancet (2004) 2.08
Tumour-associated eosinophilia: a review. J Clin Pathol (1981) 2.03
A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with post-operative radiotherapy. Oral Oncol (2006) 2.01
Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit. Aliment Pharmacol Ther (2013) 2.01
The national sentinel audit for stroke: a tool for raising standards of care. J R Coll Physicians Lond (2000) 1.97
Characterization of factors that direct transcription of rat ribosomal DNA. Mol Cell Biol (1990) 1.93
Audit of acute admissions of COPD: standards of care and management in the hospital setting. Eur Respir J (2001) 1.90
UK National COPD Audit 2003: Impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax (2006) 1.89
Infection and sepsis after operations for total hip or knee-joint replacement: influence of ultraclean air, prophylactic antibiotics and other factors. J Hyg (Lond) (1984) 1.85
Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer (2006) 1.84
Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Ann Neurol (2000) 1.82
Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread. Oral Oncol (2003) 1.81
Stroke units: research and reality. Results from the National Sentinel Audit of Stroke. Qual Saf Health Care (2005) 1.80
Benign and malignant teratomas in children: analysis of 85 patients. Surgery (1976) 1.71
Malignant eccrine poroma: a study of twenty-seven cases. Br J Dermatol (1982) 1.66
Generation of a humanized, high affinity anti-tissue factor antibody for use as a novel antithrombotic therapeutic. Thromb Haemost (2001) 1.64
Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis. Br J Urol (1982) 1.64
A randomised trial of peer review: the UK National Chronic Obstructive Pulmonary Disease Resources and Outcomes Project. Clin Med (2010) 1.62
National stroke audit: a tool for change? Qual Health Care (2001) 1.61
Predictors of speech and swallowing function following primary surgery for oral and oropharyngeal cancer. Clin Otolaryngol (2005) 1.55
Assessment of problems with appearance, following surgery for oral and oro-pharyngeal cancer using the University of Washington appearance domain and the Derriford appearance scale. Oral Oncol (2008) 1.51
Stroke thrombolysis in England, Wales and Northern Ireland: how much do we do and how much do we need? J Neurol Neurosurg Psychiatry (2010) 1.49
Changes in practice and organisation surrounding blood transfusion in NHS trusts in England 1995-2005. Qual Saf Health Care (2008) 1.47
Reliability and validity of the Intercollegiate Stroke Audit Package. J Eval Clin Pract (2001) 1.46
Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens. Protein Eng Des Sel (2008) 1.45
Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring. Eur J Obstet Gynecol Reprod Biol (1993) 1.43
Through the endoscope: a novel method of nasogastric tube insertion during oesophagoscopy. Clin Otolaryngol (2008) 1.42
Indirect laryngoscopy - the cold way. Clin Otolaryngol (2007) 1.37
Relationship between anxiety, depression, and morbidity in adult asthma patients. Thorax (2001) 1.37
Stopping rules for clinical trials incorporating clinical opinion. Biometrics (1984) 1.33
D2 gastrectomy: lessons from a prospective audit of the learning curve. Br J Surg (1996) 1.28
A review of scaphoid fracture healing in competitive athletes. Am J Sports Med (1985) 1.26
Bacteria isolated from deep joint sepsis after operation for total hip or knee replacement and the sources of the infections with Staphylococcus aureus. J Hosp Infect (1983) 1.23
Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England. J Infect (1998) 1.23
Ultraclean air and antibiotics for prevention of postoperative infection. A multicenter study of 8,052 joint replacement operations. Acta Orthop Scand (1987) 1.21
Health-related quality of life and clinical function after primary surgery for oral cancer. Br J Oral Maxillofac Surg (2002) 1.19
The use of biomarkers in biomonitoring: a 2-tier approach assessing the level of pollutant-induced stress syndrome in sentinel organisms. Comp Biochem Physiol C Toxicol Pharmacol (2007) 1.17
Prospective study of the quality of life in patients assessed for liver transplantation: outcome in transplanted and not transplanted groups. J R Soc Med (1995) 1.15
No inter-hemispheric δ13CH4 trend observed. Nature (2012) 1.13
Examining the technique of angiogenesis assessment in invasive breast cancer. Br J Cancer (1997) 1.12
In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport (1995) 1.12
A ventilation-exchange bougie for fibreoptic intubations with the laryngeal mask airway. Anaesthesia (1996) 1.10
Quality of life 5-10 years after primary surgery for oral and oro-pharyngeal cancer. J Craniomaxillofac Surg (1999) 1.10
Speed of processing in normal aging: effects of speech rate, linguistic structure, and processing time. J Gerontol (1985) 1.09
Regional variations in stroke care in England, Wales and Northern Ireland: results from the National Sentinel Audit of Stroke. Royal College of Physicians Intercollegiate Stroke Working Party. Clin Rehabil (2001) 1.09
Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: Effect of age related factors and service organisation. Thorax (2006) 1.08
Improving clinical practice in stroke through audit: results of three rounds of National Stroke Audit. J Eval Clin Pract (2005) 1.08
Measures of total free radical activity in critically ill patients. Clin Biochem (1999) 1.07
Comments on: the feasibility of balloon sinuplasty in patients with chronic rhinosinusitis: the Graz experience. Rhinology (2014) 1.07
The permeability barrier of Haemophilus influenzae type b against beta-lactam antibiotics. J Antimicrob Chemother (1983) 1.07
The influence of aging and attentional demands on recovery from postural instability. Aging (Milano) (1990) 1.06
The development of a Patients Concerns Inventory (PCI) to help reveal patients concerns in the head and neck clinic. Oral Oncol (2008) 1.06
IRS pleckstrin homology domains bind to acidic motifs in proteins. J Biol Chem (1998) 1.05
Ultrasound of the sinuses: a worthwhile procedure? A comparison of ultrasound and radiography in predicting the findings of proof puncture on the maxillary sinuses. Clin Otolaryngol Allied Sci (1984) 1.03
A feasibility study of computer-assisted health-related quality of life data collection in patients with oral and oropharyngeal cancer. Int J Oral Maxillofac Surg (2006) 1.01
Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: initial experience. Radiology (1999) 1.00
Platelet transfusions in haematology patients: are we using them appropriately? Vox Sang (2012) 1.00
Changes in subarachnoid hemorrhage mortality, incidence, and case fatality in New Zealand between 1981-1983 and 1991-1993. Stroke (1998) 1.00
Fear of recurrence following head and neck cancer in the outpatient clinic. Eur Arch Otorhinolaryngol (2010) 1.00
Eosinophilia in squamous cell carcinoma of the oral cavity, external genitalia and anus--clinical correlations. Histopathology (1984) 0.99
Human papilloma virus in condyloma acuminata of the anus. J Clin Pathol (1986) 0.99
N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study. Crit Care Med (1999) 0.97
Cognitive outcome and quality of life one year after subarachnoid haemorrhage. Neurosurgery (1989) 0.97
Effect of material deprivation on Epstein-Barr virus infection in Hodgkin's disease in the West Midlands. Br J Cancer (1999) 0.97
The University of Washington head and neck cancer measure as a predictor of outcome following primary surgery for oral cancer. Head Neck (1999) 0.97
The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res (1993) 0.96
Factors associated with restricted mouth opening and its relationship to health-related quality of life in patients attending a Maxillofacial Oncology clinic. Oral Oncol (2007) 0.96
The patients' account of outcome following primary surgery for oral and oropharyngeal cancer using a 'quality of life' questionnaire. Eur J Cancer Care (Engl) (2008) 0.96
Institutionalization after stroke. Clin Rehabil (2005) 0.96
Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer. Br J Cancer (2009) 0.95
Eosinophil infiltration in keratoacanthoma and squamous cell carcinoma of the skin. Histopathology (1984) 0.95
Clinical function after primary surgery for oral and oropharyngeal cancer: an 11-item examination. Br J Oral Maxillofac Surg (2002) 0.95
Patients' perceived health status following primary surgery for oral and oropharyngeal cancer. Int J Oral Maxillofac Surg (2006) 0.94
Dopamine enhances glutamate-activated currents in spinal motoneurons. J Neurosci (1995) 0.94
Longitudinal study of gall stone prevalence at necropsy. Gut (1992) 0.93
Use of microalbuminuria as a predictor of outcome in critically ill patients. Br J Anaesth (2000) 0.93
The isolation of Phoma eupyrena from a human lesion. Arch Dermatol (1981) 0.93
Clinical profile and recurrence of nasal polyps. J Laryngol Otol (1984) 0.93
Non-compliance with treatment in patients suffering from schizophrenia: a study to evaluate possible contributing factors. Int J Soc Psychiatry (1998) 0.93
Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene. J Cereb Blood Flow Metab (1990) 0.92
Identifying appearance-related concerns in routine follow-up clinics following treatment for oral and oropharyngeal cancer. Br J Oral Maxillofac Surg (2011) 0.92
Importance-rating using the University of Washington quality of life questionnaire in patients treated by primary surgery for oral and oro-pharyngeal cancer. J Craniomaxillofac Surg (2002) 0.91
Expression of the tumour necrosis factor receptor-associated factors 1 and 2 in Hodgkin's disease. J Pathol (2001) 0.91
The clinical determinants of malignant transformation in oral epithelial dysplasia. Oral Oncol (2012) 0.91
Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group. J Natl Cancer Inst (1999) 0.91
The impact of surgery for oral cancer on quality of life as measured by the Medical Outcomes Short Form 36. Oral Oncol (1998) 0.90
A comparison of tongue and soft palate squamous cell carcinoma treated by primary surgery in terms of survival and quality of life outcomes. Int J Oral Maxillofac Surg (2005) 0.90
Photographic mapping of a tissue surface to locate fields for electron microscopy; mouse lung. Stain Technol (1971) 0.90
Patients' perception of the financial impact of head and neck cancer and the relationship to health related quality of life. Br J Oral Maxillofac Surg (2011) 0.90
Muscarinic agonists and antagonists in the treatment of Alzheimer's disease. Farmaco (2001) 0.89
Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers. Clin Exp Immunol (1986) 0.89